WuXi Biologics in Dundalk, Ireland, is contract research development and manufacturing (CRDMO) facility using hybrid, single-use, scale-out production technology for multiproduct mAb and recombinant protein drug substance. The site also houses innovative Manufacturing Science & Technology labs that supports customers with manufacturing capacity as well as product research and optimization.
This new 467,500-square-foot greenfield facility includes 2 manufacturing areas utilizing 6x1KL single-use (SU) bioreactors for perfusion and 12x4KL SU fed-batch bioreactors, making it one of the largest facilities of its kind in Europe.
